IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE | GLOBAL MARKETS

113 Pages | 43 Exhibits | 2016 Analysis | Forecasts Through 2021 Product Family: Market Reports




OVERVIEW:
In 2015, the global market for implantable cardiac rhythm management (CRM) devices was valued at $10.2bn. The overall market, which includes cardiac resynchronization therapy, implantable cardioverter defibrillator, and pacemaker systems, is forecast to expand at a moderate compound annual growth rate of 4.8% and reaching an estimated $13.5bn in unit sales. Sales attributable to ICDs accounted for approximately 44.5% of total product sales in 2015. Pacemaker unit sales accounted for the second largest share of total implantable cardiac rhythm management system sales in 2015, with an estimated market share of 32.7%. Sales of CRT systems accounted for approximately 21.7% of total implantable cardiac rhythm management device sales in 2015. The primary factors supporting market growth are demographic and epidemiological. The expansion of the elderly demographic (age 65+) throughout the world will help to drive unit sales of implantable CRM devices. The prevalence of cardiovascular diseases, including arrhythmia and heart failure, will also increase as the elderly demographic expands as a result of individuals over the age of 65 years being at increased risk of developing cardiovascular disease(s).

Topics covered by this report include:

  • Implantable cardiac rhythm management devices used in the treatment of arrhythmia and select heart failure patients
  • Global market forecasts for 2015 through 2021
  • overview of innovative technology and its impact on current markets
  • Major trends in global healthcare systems
  • Discussion of factors promoting and inhibiting growth in CRT, ICD, and pacemaker markets
  • Estimated revenues and market shares for major competitors in the implantable cardiac rhythm management device markets


TABLE OF CONTENTS:
EXECUTIVE SUMMARY 

i. Methodology 

Exhibit ES-1: Global implantable cardiac rhythm management systems market, share by country/region, 2015 
Exhibit ES-2: Global implantable cardiac rhythm management systems market, share by product type, 2015 

1. CARDIAC RHYTHM DISORDERS OVERVIEW
 
1.1 Bradycardia 
	1.1.1 Sick sinus syndrome 
	1.1.2 Heart block 
1.2 Tachycardia 
1.3 Atrial Fibrillation 
1.4 Ventricular Fibrillation 
1.5 Heart Failure 
Bibliography 

Exhibit 1-1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias across the US, Japan, and five major EU markets 
Exhibit 1-2: Cardiac arrhythmias, selected statistics for the US 
Exhibit 1-3: Estimated prevalence of atrial fibrillation across the US, Japan, and five major EU markets, 2015 

2. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES
 
2.1 Implantable Pacemakers 
	2.1.1 Temporary pacing systems 
	2.1.2 Products 
		2.1.2.1 Products in development 
2.2 Implantable Cardioverter Defibrillators 
	2.2.1 Products 
2.3 Cardiac Resynchronization Therapy Systems 
	2.3.1 Products 
Bibliography 

Exhibit 2-1: NBG code for implantable pacemaker systems 
Exhibit 2-2: NBD code and labeling for implantable cardioverter defibrillators 

3. PACEMAKERS
 
3.1 Global Competitors 
3.2 Market Forecast: US 
	3.2.1 Competitors 
3.3 Market Forecast: Europe 
	3.3.1 Competitors 
3.4 Market Forecast: Japan
	3.4.1 Competitors 
3.5 Market Forecast: Rest of the World 
	3.5.1 Competitors 
Bibliography 

Exhibit 3-1: Pacemaker systems, global market forecast, 2015-21 
Exhibit 3-2: Global pacemaker system sales by country/region, combined market forecast ($m), 2015-21 
Exhibit 3-3: Global pacemaker systems market, share by country/region, 2015 
Exhibit 3-4: Global pacemaker systems market, share by supplier, 2015 
Exhibit 3-5: US pacemaker systems, market forecast, 2015-21 
Exhibit 3-6: US pacemaker systems market, share by supplier, 2015 
Exhibit 3-7: European pacemaker systems, market forecast, 2015-21 
Exhibit 3-8: European pacemaker systems market, share by supplier, 2015 
Exhibit 3-9: Japanese pacemaker systems, market forecast, 2015-21 
Exhibit 3-10: Japanese pacemaker systems market, share by supplier, 2015 
Exhibit 3-11: Rest of the World pacemaker systems, market forecast, 2015-21 
Exhibit 3-12: Rest of the World pacemaker systems market, share by supplier, 2015 

4. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
 
4.1 Global Competitors 
4.2 Market Forecast: US 
	4.2.1 Competitors 
4.3 Market Forecast: Europe 
	4.3.1 Competitors 
4.4 Market Forecast: Japan 
	4.4.1 Competitors 
4.5 Market Forecast: Rest of the World 
	4.5.1 Competitors 
Bibliography
 
Exhibit 4-1: ICD systems, global market forecast, 2015-21 
Exhibit 4-2: Global ICD system sales by country/region, combined market forecast ($m), 2015€"21 
Exhibit 4-3: Global ICD systems market, share by country/region, 2015 
Exhibit 4-4: Global ICD systems market, share by supplier, 2015 
Exhibit 4-5: US ICD systems, market forecast, 2015-21 
Exhibit 4-6: US ICD systems market, share by supplier, 2015 
Exhibit 4-7: European ICD systems, market forecast, 2015-21 
Exhibit 4-8: European ICD systems market, share by supplier, 2015 
Exhibit 4-9: Japanese ICD systems, market forecast, 2015-21 
Exhibit 4-10: Japanese ICD systems market, share by supplier, 2015 
Exhibit 4-11: Rest of the World ICD systems, market forecast, 2015-21 
Exhibit 4-12: Rest of the World ICD systems market, share by supplier, 2015 

5. CARDIAC RESYNCHRONIZATION THERAPY DEVICES
 
5.1 Global Competitors 
5.2 Market Forecast: US 
	5.2.1 Competitors 
5.3 Market Forecast: Europe 
	5.3.1 Competitors 
5.4 Market Forecast: Japan 
	5.4.1 Competitors 
5.5 Market Forecast: Rest of the World 
	5.5.1 Competitors 
Bibliography 

Exhibit 5-1: CRT systems, global market forecast, 2015-21 
Exhibit 5-2: Global CRT system sales by country/region, combined market forecast ($m), 2015€"21 
Exhibit 5-3: Global CRT systems market, share by country/region, 2015 
Exhibit 5-4: Global CRT systems market, share by supplier, 2015
Exhibit 5-5: US CRT systems, market forecast, 2015-21 
Exhibit 5-6: US CRT systems market, share by supplier, 2015 
Exhibit 5-7: European CRT systems, market forecast, 2015-21 
Exhibit 5-8: European CRT systems market, share by supplier, 2015 
Exhibit 5-9: Japanese CRT systems, market forecast, 2015-21 
Exhibit 5-10: Japanese CRT systems market, share by supplier, 2015 
Exhibit 5-11: Rest of the World CRT systems, market forecast, 2015-21 
Exhibit 5-12: Rest of the World CRT systems market, share by supplier, 2015 

APPENDIX: COMPANY LISTING


COMPANIES COVERED:

  1. Biotronik
  2. Boston Scientific
  3. LivaNova
  4. Medtronic
  5. St. Jude Medical
Contact Us

Need help finding medtech research? Let us help you!